(Vienna, 26 August 2025) Wilfried Ellmeier, Professor of Immunobiology and Head of the Institute of Immunology, has been elected to the Council of the International Union of Immunological Societies (IUIS).
Founded in 1969, the IUIS is the world's leading umbrella organisation in the field of immunology, representing nearly 30,000 immunologists through 84 national societies, four regional associations (Europe, Latin America, Africa and Asia-Oceania) and nine associate members.
As a recognised partner of the World Health Organisation (WHO) and a member of the International Science Council (ISC), the IUIS brings together immunologists from different regions, disciplines and career stages to unite, strengthen and advance immunological science and the immunological community by promoting collaboration and scientific excellence to work towards global health solutions.
About
Wilfried Ellmeier is Professor of Immunobiology and Head of the Institute of Immunology at the Medical University of Vienna and Deputy Head of the Center for Pathophysiology, Infectiology and Immunology at MedUni Vienna.
He studied biochemistry at the University of Vienna, completed his doctoral thesis at the Research Institute for Molecular Pathology (IMP Vienna) and completed postdoctoral studies at the Skirball Institute (NYU Medical Centre) in New York. His research interests focus on epigenetic and transcriptional control mechanisms that regulate the development and function of T cells and T cell-mediated immunity. He has received several awards, including the START Prize for highly qualified young scientists from the Austrian Science Fund FWF and the Novartis Prize for Biology. Since 2019, he has also been spokesperson for an FWF-funded Special Research Programme (SFB) on ‘Histondeazetylases and T-cell-mediated immunity’. Wilfried Ellmeier is a corresponding member of the Austrian Academy of Sciences and a member of the FWF Board of Trustees. He is President (2025–2026) of the Austrian Society for Allergology and Immunology (ÖGAI). Wilfried Ellmeier also has a keen interest in European science policy and was President (2020–2021) of the BioMedical Alliance in Europe.